These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients. Kalin ML, Babich MF, Klinke WP, Hui WK. Can J Cardiol; 1990 Jul; 6(1):15-8. PubMed ID: 2310989 [Abstract] [Full Text] [Related]
7. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. Stiell IG, Clement CM, Symington C, Perry JJ, Vaillancourt C, Wells GA. Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891 [Abstract] [Full Text] [Related]
8. Myocardial uptake and pharmacodynamics of procainamide in patients with coronary heart disease and sustained ventricular tachyarrhythmias. Gillis AM, Duff HJ, Mitchell LB, Wyse DG. J Pharmacol Exp Ther; 1993 Aug; 266(2):1001-6. PubMed ID: 8355178 [Abstract] [Full Text] [Related]
9. Pharmacokinetic model-driven infusion of sufentanil and midazolam during cardiac surgery: assessment of the prospective predictive accuracy and the quality of anesthesia. Barvais L, Heitz D, Schmartz D, Maes V, Coussaert E, Cantraine F, d'Hollander A. J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):402-8. PubMed ID: 10972605 [Abstract] [Full Text] [Related]
12. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms. Masotti CS, Pierangeli A. Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction. Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Kingery JR, Coram R, Zipes DP, Flockhart DA, Kovacs RJ. Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427 [Abstract] [Full Text] [Related]
14. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias. Interian A, Zaman L, Velez-Robinson E, Kozlovskis P, Castellanos A, Myerburg RJ. J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190 [Abstract] [Full Text] [Related]
15. Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN. Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484 [Abstract] [Full Text] [Related]
16. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Ortiz M, Martín A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J, PROCAMIO Study Investigators. Eur Heart J; 2017 May 01; 38(17):1329-1335. PubMed ID: 27354046 [Abstract] [Full Text] [Related]
17. Lidocaine and sustained monomorphic ventricular tachycardia: fact or fiction. Josephson ME. Am J Cardiol; 1996 Jul 01; 78(1):82-3. PubMed ID: 8712123 [No Abstract] [Full Text] [Related]
18. Analysis of antiarrhythmic drug concentrations determined during electrophysiologic drug testing in patients with inducible tachycardias. Berry NS, Bauman JL, Gallastegui JL, Bauma W, Beckman KJ, Hariman RJ. Am J Cardiol; 1988 Apr 15; 61(11):922-4. PubMed ID: 3354470 [No Abstract] [Full Text] [Related]
19. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease. Pires LA, Wagshal AB, Greene TO, Mittleman RS, Huang SK. Am J Cardiol; 1993 Oct 15; 72(12):908-10. PubMed ID: 8105674 [Abstract] [Full Text] [Related]
20. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation. Samuels LE, Holmes EC, Samuels FL. Ann Thorac Surg; 2005 Jan 15; 79(1):113-6. PubMed ID: 15620926 [Abstract] [Full Text] [Related] Page: [Next] [New Search]